For the Inventor, By the Inventor

Enter assignee name

Lexington, MA, United States of America

Fractyl Health, Inc.

USPTO Granted Patents = 22

EPO Patents = 8

Trademarks = 11

Forward Citations = 36

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Jay D Caplan (22 out of 40 patents)

Harith Rajagopalan (21 out of 35 patents)

J Christopher Flaherty (13 out of 267 patents)

4. J Christopher Flaherty (8 out of 24 patents)

5. R Maxwell Flaherty (7 out of 40 patents)

6. Mark A Manasas (7 out of 11 patents)

7. Andrew Owen Coats (7 out of 29 patents)

8. Philip Stephen Levin (6 out of 16 patents)

9. Craig Morris Gardner (5 out of 19 patents)

10. Christopher James Kadamus (3 out of 24 patents)

11. Andrew Hollett (1 out of 1 patent)

12. Jeffrey Lesica (1 out of 1 patent)

13. J Christopher Flaherty (1 out of 1 patent)

14. Phillip S Levin (2 patents)

15. Michael Biasella (0 patent)

22 patents: Sort by Forward Citations

1. 12478426 - Injectate delivery devices, systems and methods (2025-11-25),

2. 12471979 - Energy ablation systems, devices and methods for the treatment of tissue (2025-11-18),

3. 12396777 - Ablation systems, devices and methods for the treatment of tissue (2025-08-26),

4. 12364554 - Automated tissue treatment devices, systems, and methods (2025-07-22),

5. 12329439 - Electrical energy ablation systems, devices and methods for the treatment of tissue (2025-06-17),

6. 12303185 - Electrical energy ablation systems, devices and methods for the treatment of tissue (2025-05-20),

7. 12201342 - Heat ablation systems, devices and methods for the treatment of tissue (2025-01-21),

8. 12178502 - Tissue expansion devices, systems and methods (2024-12-31),

9. 12127785 - Methods and systems for treating diabetes and related diseases and disorders (2024-10-29),

10. 12102380 - Methods, systems and devices for reducing the luminal surface area of the gastrointestinal tract (2024-10-01),

11. 12089887 - Ablation systems, devices and methods for the treatment of tissue (2024-09-17),

12. 11986235 - Systems, methods and devices for treatment of target tissue (2024-05-21),

13. 11878128 - Systems, devices and methods for performing medical procedures in the intestine (2024-01-23),

14. 11826521 - Systems, devices and methods for the creation of a therapeutic restriction in the gastrointestinal tract (2023-11-28),

15. 11565078 - Systems, devices and methods for performing medical procedures in the intestine (2023-01-31),

Fractyl Health is a biotechnology company focused on developing innovative treatments for metabolic diseases, with a primary focus on Type 2 diabetes. The company's unique approach targets the duodenum, a key organ involved in glucose metabolism, to improve insulin sensitivity and help patients better manage their diabetes. Through cutting-edge research and technology, Fractyl Health is dedicated to revolutionizing diabetes care and improving patients' quality of life.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

22 Patents

#39 in Lexington, MA

#864 in Massachusetts

#14,534 in US

#27,909 in the World

Lexington, MA, United States of America

Fractyl Health, Inc.

Forward Citations = 36

13 inventors:

Jay D Caplan (22 out of 40 patents)

Harith Rajagopalan (21 out of 35 patents)

J Christopher Flaherty (13 out of 267 patents)

4. J Christopher Flaherty (8 out of 24 patents)

5. R Maxwell Flaherty (7 out of 40 patents)

Please report any incorrect information to support@idiyas.com

Loading…